Inspections, Compliance, Enforcement, and Criminal Investigations
Bradley Industries, Inc. - Close Out Letter 4/7/14
Department of Health and Human Services
|Food and Drug Administration|
Minneapolis District Office
250 Marquette Avenue, Suite 600
Minneapolis, MN 55401
Telephone: (612) 758-7185
FAX: (612) 334-4142
April 7, 2014
Christopher J. Bradley
Bradley Industries, Inc.
520 E. Church Street
Libertyville, Illinois 60048
Dear Mr. Bradley:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter MIN 13-09 dated November 14, 2012. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Melissa I. Michurski